Share this article
Share this article
NEW YORK, Feb. 18, 2021 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Penumbra, Inc. ( Penumbra or the Company ) (NYSE: PEN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Penumbra and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On September 14, 2020, the Foundation for Financial Journalism (the FFJ ) published an article raising serious questions about the safety profile of the Company s Jet 7 Xtra Flex catheter, a flagship product. The FFJ noted that since the product s introduction in mid-2019, a U.S. Food and Drug Administration database had recorded 12 deaths associated with the product s use. On this news, Penumbra s stock price fell by nearly 3%, from $199.43 per share on September 13, 2020 to $193.66 per share on Septem
NEW YORK, NY / ACCESSWIRE / February 19, 2021 / Nationally ranked litigation firm Labaton Sucharow announces investigation of Penumbra, Inc. ("Penumbra" or the "Company") (NYSE:PEN) and encourages investors with losses to contact the firm.
/PRNewswire/ Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a.
PEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Penumbra, Inc prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.